LD-2 disclosure · 3rd Quarter - Report
INCYTE CORPORATION
Expenses$220Kself-filed spend
Client
- Location
- Delaware · United States of America
Registrant
- Description
- Biopharmaceutical Company
- Location
- Wilmington, Delaware, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
Inflation Reduction Act of 2022 (PL 117-169), Subtitle B - Prescription Drug Pricing Reform; Issues related to 340B
Lobbyistsms MELISSA WIER BANASHAK
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Issues related to intellectual property
Lobbyistsms MELISSA WIER BANASHAK
TargetedSENATE · HOUSE OF REPRESENTATIVES